Non-stem cell-derived exosomes: a novel therapeutics for neurotrauma

被引:0
作者
Xinyu Nie
Tianyang Yuan
Tong Yu
Zhihe Yun
Tao Yu
Qinyi Liu
机构
[1] The second hospital of Jilin University,Department of Orthopaedic
来源
Journal of Nanobiotechnology | / 22卷
关键词
Exosomes; Neurotrauma; Therapeutics; Tissue regeneration; Non-stem cell sources;
D O I
暂无
中图分类号
学科分类号
摘要
Neurotrauma, encompassing traumatic brain injuries (TBI) and spinal cord injuries (SCI) impacts a significant portion of the global population. While spontaneous recovery post-TBI or SCI is possible, recent advancements in cell-based therapies aim to bolster these natural reparative mechanisms. Emerging research indicates that the beneficial outcomes of such therapies might be largely mediated by exosomes secreted from the administered cells. While stem cells have garnered much attention, exosomes derived from non-stem cells, including neurons, Schwann cells, microglia, and vascular endothelial cells, have shown notable therapeutic potential. These exosomes contribute to angiogenesis, neurogenesis, and axon remodeling, and display anti-inflammatory properties, marking them as promising agents for neurorestorative treatments. This review provides an in-depth exploration of the current methodologies, challenges, and future directions regarding the therapeutic role of non-stem cell-derived exosomes in neurotrauma.
引用
收藏
相关论文
共 166 条
  • [1] Rubiano AM(2015)Global neurotrauma research challenges and opportunities Nature 527 193-7
  • [2] Hayakawa K(2018)Extracellular mitochondria for therapy and diagnosis in Acute Central Nervous System Injury JAMA Neurol 75 119-22
  • [3] Marklund N(2019)Treatments and rehabilitation in the acute and chronic state of traumatic brain injury J Intern Med 285 608-23
  • [4] Diebo BG(2019)Adult spinal deformity Lancet (London England) 394 160-72
  • [5] Milich LM(2019)The origin, fate, and contribution of macrophages to spinal cord injury pathology Acta Neuropathol 137 785-97
  • [6] Ryan CB(2019)Animal models of traumatic Brain Injury and Assessment of Injury Severity Mol Neurobiol 56 5332-45
  • [7] Lee JK(2022)A review of the pathology and treatment of TBI and PTSD Exp Neurol 351 114009-40
  • [8] Ma X(2021)Potential of different cells-derived exosomal microRNA cargos for treating spinal cord injury J Orthop Translation 31 33-109
  • [9] Monsour M(2023)Role of regulatory T cells in spinal cord injury Eur J Med Res 28 163-44
  • [10] Ebedes D(2020)Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma Exp Neurol 329 113310-100